Additional information: date based on universal time coordinated (utc).The device remains implanted in the patient; therefore, product testing on the actual device could not be performed.The device history record review of the manufacturing lot was performed and there were no non-conformities found to be related to the reported event.A review of the device labeling was completed.Malpositioned stent is identified in the labeling as a known inherent risk of trabecular micro-bypass stent procedure.The ifu adequately provides instructions for stent implantation, precautions, and warnings for the proper use and handling of the device.The reported event is an established risk associated with use of the device, which is clearly specified in the product''s labeling.Based on the information received, the root cause of the reported event was likely due to intraoperative operational context- compromised intraoperative visualization.(b)(4).
|
It was reported that during a right eye (od) a trabecular microbypass stent system procedure, the first stent from the back-up device was inadvertently implanted below the trabecular meshwork (tm) in the scleral spur.There was no report of patient injury, and the procedure was completed with a successful implant of the second stent from the back-up device.The report that noted compromised intraoperative view contributed to the reported event.Any omitted information was not available at the time of report.
|
Additional information: g3, g4.A review of the surgical video confirmed the reported event.Based on the investigation and available information, the root cause of the stent malpositioning could not be conclusively identified; however it is possible that surgical technique may have been contributed to the event.Mfr# reference: (b)(4).
|